Deep Dive Into CME Gr Stock: Analyst Perspectives (10 Ratings)
Portfolio Pulse from Benzinga Insights
Analysts have mixed views on CME Group (NASDAQ:CME) with recent ratings showing a majority of 'Indifferent' stances. The average 12-month price target is $214.0, slightly down from $214.22. Key analysts have adjusted their ratings and price targets, reflecting varied expectations for the company's performance.
June 21, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts have mixed views on CME Group with a majority of 'Indifferent' ratings. The average 12-month price target is $214.0, slightly down from $214.22. Key analysts have adjusted their ratings and price targets, reflecting varied expectations for the company's performance.
The majority of analysts have an 'Indifferent' stance on CME Group, indicating a neutral outlook. The slight decrease in the average price target suggests limited short-term impact on the stock price. However, the varied adjustments in ratings and price targets by key analysts reflect differing expectations for the company's performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100